Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis
dc.contributor.author | Miceli, Marisa H. | en_US |
dc.contributor.author | Goggins, Michael I. | en_US |
dc.contributor.author | Chander, Pranay | en_US |
dc.contributor.author | Sekaran, Archana K. | en_US |
dc.contributor.author | Kizy, Anne E. | en_US |
dc.contributor.author | Samuel, Linoj | en_US |
dc.contributor.author | Jiang, Hui | en_US |
dc.contributor.author | Thornton, Christopher R. | en_US |
dc.contributor.author | Ramesh, Mayur | en_US |
dc.contributor.author | Alangaden, George | en_US |
dc.date.accessioned | 2015-06-01T18:51:31Z | |
dc.date.available | 2016-07-05T17:27:57Z | en |
dc.date.issued | 2015-06 | en_US |
dc.identifier.citation | Miceli, Marisa H.; Goggins, Michael I.; Chander, Pranay; Sekaran, Archana K.; Kizy, Anne E.; Samuel, Linoj; Jiang, Hui; Thornton, Christopher R.; Ramesh, Mayur; Alangaden, George (2015). "Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis." Mycoses 58(6): 368-374. | en_US |
dc.identifier.issn | 0933-7407 | en_US |
dc.identifier.issn | 1439-0507 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/111755 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | diagnosis | en_US |
dc.subject.other | Aspergillus | en_US |
dc.subject.other | lateral flow device | en_US |
dc.subject.other | brochoalveolar lavage | en_US |
dc.title | Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Dentistry | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/111755/1/myc12327.pdf | |
dc.identifier.doi | 10.1111/myc.12327 | en_US |
dc.identifier.source | Mycoses | en_US |
dc.identifier.citedreference | Cahill BC, Hibbs JR, Savik K et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997; 112: 1160 – 4. | en_US |
dc.identifier.citedreference | Thompson GR, 3rd, Patterson TF. Pulmonary aspergillosis. Semin Respir Crit Care Med 2008; 29: 103 – 10. | en_US |
dc.identifier.citedreference | Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909 – 17. | en_US |
dc.identifier.citedreference | Singh N, Husain S. AST Infectious Diseases Community of Practice. Aspergillosis in solid organ transplantation. Am J Transplant 2013; 13: 228 – 41. | en_US |
dc.identifier.citedreference | von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62: 341 – 7. | en_US |
dc.identifier.citedreference | Caillot D, Couaillier JF, Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253 – 9. | en_US |
dc.identifier.citedreference | De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813 – 21. | en_US |
dc.identifier.citedreference | Mennink‐Kersten MA, Verweij PE. Non‐culture‐based diagnostics for opportunistic fungi. Infect Dis Clin North Am 2006; 20: 711 – 27. | en_US |
dc.identifier.citedreference | Zou M, Tang L, Zhao S et al. Systematic review and meta‐analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS ONE 2012; 7: e43347. | en_US |
dc.identifier.citedreference | Thornton CR. Development of an immunochromatographic lateral‐flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 2008; 15: 1095 – 105. | en_US |
dc.identifier.citedreference | Thornton CR. Detection of invasive aspergillosis. Adv Applied Microbiol 2010; 70: 187 – 216. | en_US |
dc.identifier.citedreference | Hoenigl M, Koidl C, Duettmann W et al. Bronchoalveolar lavage lateral‐flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Infection 2012; 65: 588 – 91. | en_US |
dc.identifier.citedreference | Hoenigl M, Prattes J, Spiess B et al. Performance of galactomannan, beta‐d‐glucan, Aspergillus lateral‐flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2014; 52: 2039 – 45. | en_US |
dc.identifier.citedreference | Willinger B, Lackner M, Lass‐Florl C et al. Bronchoalveolar lavage lateral‐flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study. Transplantation 2014; 98: 898 – 902. | en_US |
dc.identifier.citedreference | Rüping MJGT, Vehreschild JJ, Cornely OA. Patients at high risk of invasive fungal infection: when and how to treat. Drugs 2008; 68: 1941 – 62. | en_US |
dc.identifier.citedreference | Thornton CR. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral flow technology. J Vis Exp 2012; 61: 1 – 5. | en_US |
dc.identifier.citedreference | Silveira FP, Husain S. Fungal infections in lung transplant recipients. Curr Opin Pulm Med 2008; 14: 211 – 8. | en_US |
dc.identifier.citedreference | Food and Drug Administration ‐ Detection of galactomannan in serum. [WWW document], URL http://www.accessdata.fda.gov/cdrh_docs/pdf9/K093678.pdf 2011 [accessed on 26 January 2013]. | en_US |
dc.identifier.citedreference | Food and Drug Administration ‐ Detection of galactomannan in bronchoalveolar lavage. [WWW document], http://www.accessdata.fda.gov/cdrh_docs/pdf6/K060641.pdf 2006 [accessed on 26 January 2013]. | en_US |
dc.identifier.citedreference | Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609 – 22. | en_US |
dc.identifier.citedreference | Husain S, Paterson DL, Studer SM et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 2007; 83: 1330 – 6. | en_US |
dc.identifier.citedreference | Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme‐linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257 – 60. | en_US |
dc.identifier.citedreference | Kappe R, Schulze‐Berge A. New cause for false‐positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993; 31: 2489 – 90. | en_US |
dc.identifier.citedreference | Clancy CJ, Jaber RA, Leather HL et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid‐organ transplant recipients. J Clin Microbiol 2007; 45: 1759 – 65. | en_US |
dc.identifier.citedreference | Wheat LJ, Nguyen MH, Alexander B et al. Long‐term stability at −20°C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens. J Clinc Microbiol 2014; 52: 2108 – 11. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.